Current Diabetes Reports

, Volume 6, Issue 3, pp 251–258 | Cite as

The role of complementary and alternative medicine in diabetes

  • Shefali Dham
  • Viral Shah
  • Sondra Hirsch
  • Mary Ann Banerji


Complementary and alternative medicine (CAM) describes a diverse group of medical and health care systems, practices, and products not currently considered to be part of conventional medicine. Inadequacies in current treatments for diabetes have led 2 to 3.6 million Americans to use CAM for diabetes treatment, despite limited studies of safety and efficacy of CAM methods. CAM is used mostly by West Indians, Africans, Indians, Latin Americans, or Asians. Prayer, acupuncture, massage, hot tub therapy, biofeedback, and yoga have been used as well as various plant remedies for treating diabetes. Several CAM practices and herbal remedies are promising for diabetes treatment, but further rigorous study is needed in order to establish safety, efficacy, and mechanism of action. In the meantime, it is important to be aware that many patients with diabetes may be using CAM and to consider potential interactions with conventional medicines being used.


Herbal Remedy Curcuma Longa Momordica Charantia Tibetan Medicine Panax Quinquefolius 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    National Center for Complementary and Alternative Medicine (NCCAM): Major domains of complementary and alternative medicine. http:/ Useful overview of CAM.Google Scholar
  2. 2.
    American Diabetes Association: Unproven therapies (position statement). Diabetes Care 2004, 27(suppl 1):S135.Google Scholar
  3. 3.
    Eisenberg DM, Davis RB, Ettner SL, et al.: Trends in alternative medicine use in the United States, 1990–1997: results of a follow-up national survey. JAMA 1998, 280:1569–1575.PubMedCrossRefGoogle Scholar
  4. 4.
    Egede LE, Ye X, Zheng D, Silverstein MD: The prevalence and pattern of complementary and alternative medicine use in individuals with diabetes. Diabetes Care 2002, 25:324–329.PubMedCrossRefGoogle Scholar
  5. 5.
    Ryan EA, Pick E, Marceau C: Use of alternative medicine in diabetes. Diabet Med 2001, 18:242–245.PubMedCrossRefGoogle Scholar
  6. 6.
    YehGY, Eisenberg DM, Kaptchuk TJ, Phillips RS: Systematic review of herbs and dietary supplements for glycemic control in diabetes. Diabetes Care 2003, 26:1277–1294. An excellent review of herbal remedies for diabetes.PubMedCrossRefGoogle Scholar
  7. 7.
    Payne C: Complementary and integrative medicine: emerging therapies for diabetes. Part I. Diabetes Spectrum 2001, 14:129–131.CrossRefGoogle Scholar
  8. 8.
    Chen J, Li C, Ding P, Ma Y: Effect of acupuncture on plasmic levels of insulin, glucagon and hypercoagulability in NIDDM complicated by acute cerebral infarction. J Tradit Chin Med 2001, 21:267–269.PubMedGoogle Scholar
  9. 9.
    Hu H: A review of treatment of diabetes by acupuncture during the past forty years. J Tradit Chin Med 1995, 15:145–154.PubMedGoogle Scholar
  10. 10.
    Feng M, Li Y, Pang B, et al.: Acupuncture combined with application of xiaoke plaster for treatment of 309 cases of diabetes mellitus. J Tradit Chin Med 1997, 17:247–249.PubMedGoogle Scholar
  11. 11.
    Chen D, Gong D, Zhai Y: Clinical and experimental studies in treating diabetes mellitus by acupuncture. J Tradit Chin Med 1994, 14:163–166.PubMedGoogle Scholar
  12. 12.
    Han JS: Acupuncture and endorphins. Neurosci Lett 2004, 361:258–261.PubMedCrossRefGoogle Scholar
  13. 13.
    Chen Y: Magnets on ears helped diabetics. Am J Chin Med 2002, 30:183–150.PubMedCrossRefGoogle Scholar
  14. 14.
    Wu W, Li C: Diabetes mellitus treated by massage. J Tradit Chin Med 1998, 18:64–65.PubMedGoogle Scholar
  15. 15.
    Dillon RS: Improved serum insulin profiles in diabetic individuals who massaged their insulin injection sites. Diabetes Care 1983, 6:399–401.PubMedCrossRefGoogle Scholar
  16. 16.
    Hooper PL: Hot-tub therapy for type 2 diabetes mellitus. N Engl J Med 1999, 341:924–925.PubMedCrossRefGoogle Scholar
  17. 17.
    Lane JD, McCaskill CC, Ross SL, et al.: Relaxation training for NIDDM. Predicting who may benefit. Diabetes Care 1993, 8:1087–1094.CrossRefGoogle Scholar
  18. 18.
    SurwitR, van Tilburg MAL, Zucker N, et al.: Stress management improves long term glycemic control in type 2 diabetes. Diabetes Care 2002, 25:30–34. Controlled study with a sizable number of patients.PubMedCrossRefGoogle Scholar
  19. 19.
    Feinglos MN, Hastedt P, Surwit RS: Effects of relaxation therapy on patients with type I diabetes mellitus. Diabetes Care 1987, 10:72–75.PubMedCrossRefGoogle Scholar
  20. 20.
    McGrady A, Bailey BK, Good MP: Controlled study of biofeedback-assisted relaxation in type I diabetes. Diabetes Care 1991, 14:360–365.PubMedCrossRefGoogle Scholar
  21. 21.
    Jab Lon SL, Malakoff BD, Gilmore SL, Rosenthal MJ: Effects of relaxation training on glucose tolerance and diabetic control in type II diabetes. Appl Psychophysiol Biofeedback 1997, 22:155–169.CrossRefGoogle Scholar
  22. 22.
    Malhotra V, Singh S, Singh KP, et al.: Study of yoga asanas in assessment of pulmonary function in NIDDM patients. Indian J Physiol Pharmacol 2002, 46:313–320.PubMedGoogle Scholar
  23. 23.
    Jain SC, Uppal A, Bhatnagar SO, Talukdar B: A study of response pattern of non-insulin dependent diabetics to yoga therapy. Diabetes Res Clin Pract 1993, 19:69–74.PubMedCrossRefGoogle Scholar
  24. 24.
    Parshad O: Role of yoga in stress management. West Indian Med J 2004, 53:191–194.PubMedGoogle Scholar
  25. 25.
    Bjorntorp P, Holm G, Rosmond R: Hypothalamic arousal, insulin resistance and type 2 diabetes mellitus. Diabet Med 1999, 16:373–383.PubMedCrossRefGoogle Scholar
  26. 26.
    Tsigos C, Chrousos GP: Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress. J Psychosom Res 2002, 53:865–871.PubMedCrossRefGoogle Scholar
  27. 27.
    Smith EL, Batuman OA, Trost RC, et al.: Transforming growth factor-beta 1 and cortisol in differentially reared primates. Brain Behav Immun 2002, 16:140–149.PubMedCrossRefGoogle Scholar
  28. 28.
    Gohil BC, Rosenblum LA, Coplan JD, Kral JG: Hypothalamic-pituitary-adrenal axis function and the metabolic syndrome X of obesity. CNS Spectr 2001, 6:581–589.PubMedGoogle Scholar
  29. 29.
    YehGY, Eisenberg DM, Davis RB, Phillips RS: Use of complementary and alternative medicine among persons with diabetes mellitus: results of a national survey. Am J Public Health 2002, 92:1648–1652. Excellent comprehensive survey of CAM.PubMedGoogle Scholar
  30. 30.
    Bailey CJ, Day C: Traditional plant medicines as treatments for diabetes. Diabetes Care 1989, 12:553–564.PubMedCrossRefGoogle Scholar
  31. 31.
    Azad Khan AK, Akhtar S, Mahtab H: Coccinia indica in the treatment of patients with diabetes mellitus. Bangladesh Med Res Counc Bull 1979, 5:60–66.Google Scholar
  32. 32.
    Vuksan V, Sievenpiper JL, Koo V YY, et al.: American ginseng (Panax quinquefolius L) reduces postprandial glycemia in non-diabetic subjects and subjects with type 2 diabetes mellitus. Arch Intern Med 2000, 160:1009–1013.PubMedCrossRefGoogle Scholar
  33. 33.
    Vuksan V, Stavro MP, Sievenpiper JL, et al.: Similar postprandial glycemic reductions with escalation of dose and administration time of American ginseng in type 2 diabetes. Diabetes Care 2000, 23:1221–1226.PubMedCrossRefGoogle Scholar
  34. 34.
    Frati-Munari AC, Gordillo BE, Altamirano P, Ariza CR:Hypoglycemic effect of Opuntia streptacantha Lemaire in NIDDM. Diabetes Care 1988, 11:63–66.PubMedCrossRefGoogle Scholar
  35. 35.
    Ludvik B, Neuffer B, Pacini G: Efficacy of Ipomoea batatas (Caiapo) on diabetes control in type 2 diabetic subjects treated with diet. Diabetes Care 2004, 27:436–440.PubMedCrossRefGoogle Scholar
  36. 36.
    Gupta A, Gupta R, Lal B: Effect of Trigonella foenum-graecum (fenugreek) seeds on glycaemic control and insulin resistance in type 2 diabetes mellitus: a double blind placebo controlled study. J Assoc Physicians India 2001, 49:1057–1061.PubMedGoogle Scholar
  37. 37.
    Yajima H, Ikeshima E, Shiraki M, et al.: Isohumulones, bitter acids derived from hops activate both peroxisome proliferators-activated receptor alpha and gamma and reduce insulin resistance. J Biol Chem 2004, 279:33256–33462.CrossRefGoogle Scholar
  38. 38.
    Hsia SH, Bazargan M, Davidson MB: Effect of Pancreas Tonic (an ayurvedic herbal supplement) in type 2 diabetes mellitus. Metabolism 2004, 53:1166–1173.PubMedCrossRefGoogle Scholar
  39. 39.
    Khan A, Safdar M, Ali Khan MM, et al.: Cinnamon improves glucose and lipids of people with type 2 diabetes. Diabetes Care 2003, 26:3215–3218.PubMedCrossRefGoogle Scholar
  40. 40.
    Namdul T, Sood A, Ramakrishnan L, et al.: Efficacy of Tibetan medicine as an adjunct in the treatment of type 2 diabetes. Diabetes Care 2001, 24:175–176.PubMedCrossRefGoogle Scholar
  41. 41.
    Frati AC, Gordillo BE, Altamirano P, et al.: Acute hypoglycemic effects of Opuntia streptacantha Lemaire in NIDDM [letter]. Diabetes Care 1990, 13:455–456.PubMedGoogle Scholar
  42. 42.
    Leatherdale BA, Panesar RK, Singh G, et al.: Improvement in glucose tolerance due to Momordica charantia (karela). BMJ 1981, 282:1823–1824.PubMedCrossRefGoogle Scholar
  43. 43.
    Fujita H, Yamagami T, Ohshima K: Long-term ingestion of a fermented soybean-derived Touchi-extract with alphaglucosidase inhibitory activity is safe and effective in humans with borderline and mild type-2 diabetes. J Nutr 2001, 131:2105–2108.PubMedGoogle Scholar
  44. 44.
    Shekhar KC, Achike FI, Kaur G, et al.: A preliminary evaluation of the efficacy and safety of Cogent db (an ayurvedic drug) in the glycemic control of patients with type 2-diabetes. J Altern Complement Med 2002, 8:445–457.PubMedCrossRefGoogle Scholar
  45. 45.
    Baskaran K, Ahamath BK, Shanmugasundaram KR, Shanmugasundaram ERB: Antidiabetic effect of a leaf extract from Gymnema sylvestre in non-insulin dependent diabetes mellitus patients. J Ethnopharmacol 1990, 30:295–305.PubMedCrossRefGoogle Scholar
  46. 46.
    Flexible dose open trial of Vijayasar in cases of newlydiagnosed non-insulin-dependent diabetes mellitus. Indian Council of Medical Research (ICMR), Collaborating Centres, New Delhi [no authors listed]. Indian J Med Res 1998, 108:24–29.Google Scholar
  47. 47.
    Hosoda K, Wang MF, Liao ML, et al.: Antihyperglycemic effect of oolong tea in type 2 diabetes. Diabetes Care 2003, 26:1714–1718.PubMedCrossRefGoogle Scholar
  48. 48.
    Serraclara A, Hawkins F, Perez C, et al.: Hypoglycemic action of an oral fig-leaf decoction in type-I diabetic patients. Diabetes Res Clin Pract 1998, 39:19–22.PubMedCrossRefGoogle Scholar
  49. 49.
    Jia W, Gao W, Tang L: Anti-diabetic herbal drugs officially approved in China. Phytother Res 2003, 17:1127–1134.PubMedCrossRefGoogle Scholar
  50. 50.
    Kimble SM, Joystick GS, Kamala PL, Vida SM: Efficacy of Coccinia indica W & A in diabetes mellitus. J Res Ayurveda Sridhar 1996, XVII:77–84.Google Scholar
  51. 51.
    Kamble SM, Kamala PL, Vida S, Bamboozle VD: Influence of Coccinia indica on certain enzymes in glycolytic and lipolytic pathway in human diabetes. Indian J Med Sci 1986, 52:143–146.Google Scholar
  52. 52.
    Kuppurajan K, Seshadri C, Revathi R, Venkataraghavah S: Hypoglycaemic effect of Coccinia indica in diabetes mellitus. Nagarjun 1986, 29:1–4.Google Scholar
  53. 53.
    Shapiro K, Gong WC: Natural products used for diabetes. J Am Pharm Assoc 2002, 42:217–226.CrossRefGoogle Scholar
  54. 54.
    Welhinda J, Karunanayake EH, Sheriff MHR, Jayasinghe KSA: Effect of Momordica charantia on the glucose tolerance in maturity onset diabetes. J Ethnopharmacol 1986, 17:277–282.CrossRefGoogle Scholar
  55. 55.
    Akhtar MS, Ahar MA, Yaqub M: Effect of Momordica charantia on blood glucose levels of normal and alloxandiabetic rabbits. Planta Medica 1981, 42:205–221.CrossRefGoogle Scholar
  56. 56.
    Shanmugasundaram ERB, Rajeswari G, Baskaran K, et al.: Use of Gymnema sylvestre leaf extract in the control of blood glucose in insulin-dependent diabetes mellitus. J Ethnopharmacol 1990, 30:281–294.PubMedCrossRefGoogle Scholar
  57. 57.
    Sievenpiper JL, Arnason JT, Leiter LA, Vuksan V: Decreasing, null and increasing effects of eight popular types of ginseng on acute post prandial glycemic indices in healthy humans: the role of ginsenosides. J Am Coll Nutr 2004, 23:248–258.PubMedGoogle Scholar
  58. 58.
    Lee H, Gonzalez FJ, Yoon M: Ginsenoside Rf, a component of ginseng, regulates lipoprotein metabolism through peroxisome proliferator-activated receptor alpha. Biochem Biophys Res Commun 2006, 339:196–203.PubMedCrossRefGoogle Scholar
  59. 59.
    Yongchaiyudha S, Rungpitarangsi V, Bunyapraphatsara N, Chokechaijaroenporn O: Antidiabetic activity of Aloe vera L. juice. I. Clinical trial in new cases of diabetes mellitus. Phytomedicine 1996, 3:241–243.Google Scholar
  60. 60.
    Bunyapraphatsara N, Yongchaiyudha S, Rungpitarangsi V, Chokechaijaroenporn O: Antidiabetic activity of Aloe vera L juice. II Clinical trial in diabetes mellitus patients in combination with glibenclamide. Phytomedicine 1996, 3:245–248.Google Scholar

Copyright information

© Current Science Inc. 2006

Authors and Affiliations

  • Shefali Dham
  • Viral Shah
  • Sondra Hirsch
  • Mary Ann Banerji
    • 1
  1. 1.SUNY Downstate Medical Center and Kings County HospitalBrooklynUSA

Personalised recommendations